ProCE Banner Activity

Optimizing CAR T-Cell Therapies in R/R FL

Slideset

Learn more about the importance and role of CAR T-cell therapies in the management of patients with R/R FL.

Released: December 04, 2024

Expiration: December 03, 2025

Share

Faculty

Caron Jacobson

Caron Jacobson, MD

Associate Professor of Medicine
Harvard Medical School
Medical Director, Immune Effector Cell Therapy Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC in partnership with Follicular Lymphoma Foundation.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca; Genmab US, Inc.; and Ipsen Biopharmaceuticals, Inc.

AstraZeneca

Genmab US, Inc.

Ipsen Biopharmaceuticals Inc

Partners

Follicular Lymphoma Foundation

ProCE Banner